Tesla Model 3: Delivery Delayed to April-May 2024.by Lilu Anderson 14.02.2024Tesla Model 3 Highland Long Range delivery for April-May 2024, signaling high demand and production constraints. Analysts remain optimistic about ...
Apple and Microsoft Take On EU’s Tech Regulationsby Lilu Anderson 14.02.2024Apple and Microsoft have secured exemptions from the EU's new tech regulations, highlighting the nuanced understanding regulators have towards different ...
Apple Unveils EU-Mandated Updates in iOS 17.4, watchOS 10.4, and macOS 14.4 Beta 3by Lilu Anderson 14.02.2024Apple releases iOS 17.4, watchOS 10.4, and macOS 14.4 Beta 3 with EU-imposed changes. Updates promise improved features and enhanced ...
Oil Prices Surge: WTI and Brent Eye New 2024 Peaksby Terry Bingman 13.02.2024Oil prices continue to rise for the seventh day in a row, with WTI and Brent aiming for new 2024 ...
Denmark Market Slips: Top Winners and Losers Revealedby Mark Eisenberg 13.02.2024Denmark stocks fell as various sectors weighed on shares, with falling stocks outnumbering advancing ones. Genmab reached a three-year low. ...
Tesla Wins: Major Automakers Embrace NACS by 2025by Lilu Anderson 13.02.2024Tesla's North American Charging Standard (NACS) has become the industry standard for major automakers, simplifying the charging process for EV ...
Germany Plans to Sell 30% Stake in Uniper to Recover Bailout Fundsby Mark Eisenberg 13.02.2024Germany plans to sell up to 30% stake in Uniper to recover funds spent on the rescue operation during the ...
Google’s €25M AI Investment to Propel EU Forwardby Lilu Anderson 13.02.2024Google has announced a €25 million investment in AI training programs for European workers. The initiative aims to equip individuals ...
EU Clears Apple, Microsoft: iMessage and Edge Exemptby Lilu Anderson 13.02.2024The EU has cleared Apple and Microsoft's iMessage and Edge browser from the Digital Markets Act, meaning no changes are ...
Coya Therapeutics Secures Key Therapy Licenseby Lilu Anderson 13.02.2024Clinical-stage biotech company Coya Therapeutics expands its IP portfolio with a license for a novel combination therapy using low dose ...